Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Radiopharmaceuticals Market Share, Size, Trends, Drivers : By Generators Type: W-188/Re-188 Generators, Mo-99/Tc-99m Generators, Sr-82/Rb-82 Generators, Sr-90/Y-90 Generators, Ge-68/Ga-67,68 Generators; By Application: Diagnostic Radiopharmaceuticals, Others; By End Use; Regional Analysis; Competitive Landscape; 2023-2028
Global Radiopharmaceuticals Market Outlook
The global radiopharmaceuticals market attained a value of about USD 4.3 billion in 2020. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 7.5% to reach nearly USD 6.7 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America Market to Continue Dominating the Overall Market Over the Forecast Period
Owing to the presence of prominent pharmaceutical key players and well-funded research facilities, the North America region is estimated to maintain its dominance over the market share for radiopharmaceuticals. Meanwhile, the steady growth of the industry in leading Asia Pacific countries make a worthwhile contribution to the rising regional industry, which is projected to witness the fastest growth in the coming years. The SPECT segment, among the diagnostic radiopharmaceuticals, is extensively utilised in the maintenance of thyroid-related medical issues. Attributing to the commonality of these issues, the thyroid applications of radiopharmaceuticals is likely to witness robust growth during the forecast period. Moreover, under the therapeutic segment, oncology applications are estimated to grow in the coming years owing to a continual rise in the number of cancer cases. Although, due to the higher presence of alternatives in the therapeutic segment, the diagnostic pharmaceuticals are projected to achieve higher growth.
Radiopharmaceuticals: Market Segmentation
A radiopharmaceutical, also known as a medicinal radio compound, is a pharmaceutical drug containing radioisotopes that can be used as a diagnosis medication, as well as a therapeutic agent. Radiopharmaceuticals can be used for both chronic and critical diseases and are widely used in molecular imaging as biomarkers.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By generators type, the market is segmented into:
- W-188/Re-188 Generators
- Mo-99/Tc-99m Generators
- Sr-82/Rb-82 Generators
- Sr-90/Y-90 Generators
- Ge-68/Ga-67,68 Generators
Based on application, the industry can be divided into:
- Diagnostic Radiopharmaceuticals
- SPECT (Single-Photon Emission Computed Tomography)
- PET (Positron Emission Tomography)
- Therapeutic Radiopharmaceuticals
- Oncology
- Cardiology and Neurology
- Theranostics
The end uses for radiopharmaceuticals include:
- Hospitals
- Diagnostic Centres
The EMR report looks into the regional markets of radiopharmaceuticals like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Higher Prevalence of Chronic Diseases Likely to Bolster the Market Growth for Radiopharmaceuticals
The radiopharmaceuticals sector is the fastest-growing segment in the pharmaceutical industry. The global market of radiopharmaceuticals is primarily propelled by the worldwide need for timely diagnostics and treatment of fatal diseases. Unhealthy lifestyles of people all over the world has resulted in a higher prevalence of chronic diseases in recent years, and subsequently, the revolutionary utilisation of radiopharmaceuticals in diagnostics is gaining popularity in the healthcare sector.
Moreover, rising acceptance of disease specific therapy, enhanced patient awareness regarding accurate and timely diagnosis, and expanding applications of molecular imaging are some other factors providing a boost to the market growth for radiopharmaceuticals. Meanwhile, various factors including supply volatility and competition from conventional diagnostic procedures, are likely to impede the market growth. Nevertheless, constant growth in the research and development sector, and high capital investment are estimated to counter any such hurdles.
Key Industry Players in the Global Radiopharmaceuticals Market
The report presents a detailed analysis of the following key players in the global radiopharmaceuticals market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Jubilant Pharma Holdings Inc.
- Clarity Pharmaceutical
- Cardinal Health
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Generators Type, Application, End Use, Region |
| Breakup by Generators Type | W-188/Re-188 Generators, Mo-99/Tc-99m Generators, Sr-82/Rb-82 Generators, Sr-90/Y-90 Generators, Ge-68/Ga-67,68 Generators |
| Breakup by Application | Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals, Theranostics |
| Breakup by End Use | Hospitals, Diagnostic Centres |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Jubilant Pharma Holdings Inc., Clarity Pharmaceuticals, Cardinal Health, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Radiopharmaceuticals Market Analysis
8.1 Key Industry Highlights
8.2 Global Radiopharmaceuticals Historical Market (2018-2022)
8.3 Global Radiopharmaceuticals Market Forecast (2023-2028)
8.4 Global Radiopharmaceuticals Market by Generators Type
8.4.1 W-188/Re-188 Generators
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Mo-99/Tc-99m Generators
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Sr-82/Rb-82 Generators
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Sr-90/Y-90 Generators
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2018-2022)
8.4.4.3 Forecast Trend (2023-2028)
8.4.5 Ge-68/Ga-67,68 Generators
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2018-2022)
8.4.5.3 Forecast Trend (2023-2028)
8.5 Global Radiopharmaceuticals Market by Application
8.5.1 Diagnostic Radiopharmaceuticals
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.1.4 Breakup By Type
8.5.1.4.1 SPECT (Single-Photon Emission Computed Tomography)
8.5.1.4.2 PET (Positron Emission Tomography)
8.5.2 Therapeutic Radiopharmaceuticals
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.2.4 Breakup by Type
8.5.2.4.1 Oncology
8.5.2.4.2 Cardiology and Neurology
8.5.3 Theranostics
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.6 Global Radiopharmaceuticals Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Diagnostic Centres
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.7 Global Radiopharmaceuticals Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Radiopharmaceuticals Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Radiopharmaceuticals Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Radiopharmaceuticals Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Radiopharmaceuticals Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Radiopharmaceuticals Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Jubilant Pharma Holdings Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Clarity Pharmaceuticals
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Cardinal Health
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Radiopharmaceuticals Market: Key Industry Highlights, 2018 and 2028
2. Global Radiopharmaceuticals Historical Market: Breakup by Generators Type (USD Million), 2018-2022
3. Global Radiopharmaceuticals Market Forecast: Breakup by Generators Type (USD Million), 2023-2028
4. Global Radiopharmaceuticals Historical Market: Breakup by Application (USD Million), 2018-2022
5. Global Radiopharmaceuticals Market Forecast: Breakup by Application (USD Million), 2023-2028
6. Global Radiopharmaceuticals Historical Market: Breakup by End User Application (USD Million), 2018-2022
7. Global Radiopharmaceuticals Market Forecast: Breakup by End User Application (USD Million), 2023-2028
8. Global Radiopharmaceuticals Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Radiopharmaceuticals Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Radiopharmaceuticals Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Radiopharmaceuticals Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Radiopharmaceuticals Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Radiopharmaceuticals Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Radiopharmaceuticals Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Radiopharmaceuticals Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Radiopharmaceuticals Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Radiopharmaceuticals Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Radiopharmaceuticals Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Radiopharmaceuticals Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Radiopharmaceuticals Market Structure
Key Questions Answered in the Report
The global radiopharmaceuticals market attained a value of nearly USD 4.3 billion in 2020.
The market is projected to grow at a CAGR of 7.5% in the forecast period of 2023-2028.
The market is estimated to witness healthy growth in the forecast period of 2023-2028 to reach about USD 6.7 billion by 2026.
The deployment of radiopharmaceuticals in SPECT diagnosis owing to the commonality of thyroid, and the oncology segment of therapeutics is driving the market growth.
The rising prevalence of radiopharmaceuticals to effectively diagnose and treat chronic diseases caused by unhealthy lifestyle is expected to propel the market growth of radiopharmaceuticals.
The major regional markets for radiopharmaceuticals are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The different types of generators used in the radiopharmaceutical industry are W-188/Re-188 generators, Mo-99/Tc-99m generators, Sr-82/Rb-82 generators, Sr-90/Y-90 generators, and Ge-68/Ga-67,68 generators.
The significant applications of radiopharmaceuticals are diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals, and theranostics.
The major end use sectors of the radiopharmaceutical industry are hospitals, and diagnostic centres.
The major players in the industry are Jubilant Pharma Holdings Inc., Clarity Pharmaceuticals, and Cardinal Health, among others.
Analyst Review
The global radiopharmaceuticals market attained a value of about USD 4.3 billion in 2020, driven by rising applications in diagnostic and therapeutic segment. Aided by constant research and development and rising investments in the industry, the market is expected to grow at a CAGR of 7.5% in the forecast period of 2023-2028 to reach nearly USD 6.7 billion by 2026.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The different types of generators deployed in the industry are W-188/Re-188 generators, Mo-99/Tc-99m generators, Sr-82/Rb-82 generators, Sr-90/Y-90 generators, and Ge-68/Ga-67,68 generators. The significant applications of radiopharmaceuticals are diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals, and theranostics. The end-use sectors of radiopharmaceuticals are hospitals, and diagnostic centres. The major regional markets for radiopharmaceuticals are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa. The key players in the industry are Jubilant Pharma Holdings Inc., Clarity Pharmaceutical, and Cardinal Health, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER